Brief: Addex Therapeutics Q2 Net Income at CHF 12.9 Million
30/09/2024 06:08
Sep 30 (Reuters) - Addex Therapeutics Q2 operating income CHF -899 thousand. * Q2 net income CHF 12.879 million * Q2 EPS CHF 0.08
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand